JP2024533396A5 - - Google Patents

Info

Publication number
JP2024533396A5
JP2024533396A5 JP2024515444A JP2024515444A JP2024533396A5 JP 2024533396 A5 JP2024533396 A5 JP 2024533396A5 JP 2024515444 A JP2024515444 A JP 2024515444A JP 2024515444 A JP2024515444 A JP 2024515444A JP 2024533396 A5 JP2024533396 A5 JP 2024533396A5
Authority
JP
Japan
Prior art keywords
trna
nucleic acid
recombinant
sequence
genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533396A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076106 external-priority patent/WO2023039468A1/en
Publication of JP2024533396A publication Critical patent/JP2024533396A/ja
Publication of JP2024533396A5 publication Critical patent/JP2024533396A5/ja
Pending legal-status Critical Current

Links

JP2024515444A 2021-09-08 2022-09-08 ウイルスガイドrna送達 Pending JP2024533396A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163241964P 2021-09-08 2021-09-08
US63/241,964 2021-09-08
PCT/US2022/076106 WO2023039468A1 (en) 2021-09-08 2022-09-08 Viral guide rna delivery

Publications (2)

Publication Number Publication Date
JP2024533396A JP2024533396A (ja) 2024-09-12
JP2024533396A5 true JP2024533396A5 (cg-RX-API-DMAC10.html) 2025-09-26

Family

ID=84053434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515444A Pending JP2024533396A (ja) 2021-09-08 2022-09-08 ウイルスガイドrna送達

Country Status (8)

Country Link
US (1) US20230270840A1 (cg-RX-API-DMAC10.html)
EP (1) EP4399303A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024533396A (cg-RX-API-DMAC10.html)
KR (1) KR20240141708A (cg-RX-API-DMAC10.html)
CN (1) CN118369429A (cg-RX-API-DMAC10.html)
AU (1) AU2022343725A1 (cg-RX-API-DMAC10.html)
CA (1) CA3230629A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023039468A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121575112B (zh) * 2026-01-28 2026-04-24 中南大学湘雅医院 检测用于结肠癌诊断的tsRNA的试剂和试剂盒的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4921757A (en) 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
JPH0825869B2 (ja) 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
US4911928A (en) 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US4917951A (en) 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
US6503717B2 (en) 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
JP2003514564A (ja) 1999-11-24 2003-04-22 エムシーエス マイクロ キャリア システムズ ゲーエムベーハー 核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法
AU2001250774B2 (en) 2000-02-08 2005-01-27 Sangamo Biosciences, Inc. Cells expressing zinc finger proteins for drug discovery
HUE041426T2 (hu) 2009-11-02 2019-05-28 Univ Washington Terápiás nukleáz-készítmények és eljárások
BR112017007923B1 (pt) * 2014-10-17 2023-12-12 The Penn State Research Foundation Método para produzir manipulação genética mediada por reações multiplex com rna em uma célula receptora, construção de ácido nucleico,cassete de expressão, vetor, célula receptora e célula geneticamente modificada
PL3346983T3 (pl) 2015-09-11 2020-11-16 Wm. Wrigley Jr. Company Synergistyczne działanie przeciwbakteryjne ekstraktu kory magnolii i L-argininy, estru N-alfa-etylowo-lauroilowego na bakterie występujące w ślinie
CN105139759B (zh) 2015-09-18 2017-10-10 京东方科技集团股份有限公司 一种拼接屏
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
GB201706945D0 (en) * 2017-05-02 2017-06-14 Medical Res Council Self-inactivating viral vector
JP2020038883A (ja) 2018-09-03 2020-03-12 株式会社オートネットワーク技術研究所 回路構造体及び回路構造体の製造方法
CN109722437B (zh) * 2018-12-29 2020-01-07 广州百暨基因科技有限公司 一种通用型car-t细胞及其制备方法和用途
WO2021129895A2 (zh) * 2019-12-23 2021-07-01 浙江大学 侵染性植物弹状病毒载体及无转基因植物基因组定点编辑的方法
JP2024507533A (ja) * 2021-02-19 2024-02-20 ビーム・セラピューティクス・インコーポレイテッド 遺伝子治療のための組み換え狂犬病ウイルス
EP4314305A4 (en) * 2021-03-26 2025-07-30 Univ North Carolina State RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE

Similar Documents

Publication Publication Date Title
US12065669B2 (en) Methods and compositions for modulating a genome
US20240417757A1 (en) Methods and compositions for modulating a genome
US20230242899A1 (en) Methods and compositions for modulating a genome
DE69429260T2 (de) Adenovirale vektoren tierischen ursprungs und ihre verwendung bei der gentherapie
US20230329201A1 (en) Cells and non-human animals engineered to express adar1 and uses thereof
AU760770B2 (en) Episomally relicating vector, its preparation and use
JP2024507533A5 (cg-RX-API-DMAC10.html)
US20030157494A1 (en) Smooth muscle cell promoter and uses thereof
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
JP2025510586A5 (cg-RX-API-DMAC10.html)
CN117568334A (zh) 用具有工程化稳定的内源性foxp3基因表达的cd4 t细胞治疗自身免疫疾病的方法
US20250312376A1 (en) Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells
EP1075529B1 (en) Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
KR19980071443A (ko) 구조 유전자의 세포 주기 조절된 발현을 위한 핵산 작제물
US6881724B2 (en) Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
CN112567053A (zh) 重组核酸构建体
JP2001515713A5 (cg-RX-API-DMAC10.html)
JP2024521750A5 (cg-RX-API-DMAC10.html)
CN121752723A (zh) 编码crispr相关蛋白的核酸及其应用
CN121443627A (zh) 经修饰的降解决定子多肽和其用途
US7368553B2 (en) Alternatively spliced nucleic acid molecules
Samara et al. Molecular biology and therapy of disease
Whalen Promoters, enhancers, and inducible elements for gene therapy
US7297535B2 (en) Use of the human LRP/MVP promotor for a vector that can be induced by therapy
KR19990072793A (ko) Dna서열의유전자수송을위한아데노바이러스전달벡터